Back to Search
Start Over
Should LHRH therapy be continued in patients receiving abiraterone acetate?
- Source :
-
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2022 Apr; Vol. 25 (4), pp. 798-799. Date of Electronic Publication: 2022 Aug 26. - Publication Year :
- 2022
- Subjects :
- Male
Humans
Antineoplastic Agents, Hormonal therapeutic use
Gonadotropin-Releasing Hormone therapeutic use
Antineoplastic Combined Chemotherapy Protocols adverse effects
Prednisone therapeutic use
Abiraterone Acetate adverse effects
Prostatic Neoplasms, Castration-Resistant drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5608
- Volume :
- 25
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Prostate cancer and prostatic diseases
- Publication Type :
- Editorial & Opinion
- Accession number :
- 36028658
- Full Text :
- https://doi.org/10.1038/s41391-022-00584-9